Engineering supramolecular dynamics of self-assembly and turnover of oncogenic microRNAs to drive their synergistic destruction in tumor models

Daria Chiglintseva, David Clarke, Aleksandra Sen’kova, Tom Heyman, Svetlana Miroshnichenko, Fangzhou Shan, Valentin Vlassov, Marina Zenkova, Olga Patutina (Corresponding), Elena Bichenkova (Lead)

Research output: Contribution to journalArticlepeer-review

10 Downloads (Pure)

Abstract

Rationally-engineered functional biomaterials offer the opportunity to interface with complex biology in a predictive, precise, yet dynamic way to reprogram their behaviour and correct shortcomings. Success here may lead to a desired therapeutic effect against life-threatening diseases, such as cancer. Here, we engineered “Crab”-like artificial ribonucleases through coupling of peptide and nucleic acid building blocks, capable of operating alongside and synergistically with intracellular enzymes (RNase H and Ago 2) for potent destruction of oncogenic microRNAs. “Crab”-like configuration of two catalytic peptides (“pincers”) flanking the recognition oligonucleotide was instrumental here in providing increased catalytic turnover, leading to ≈30-fold decrease in miRNA half-life as compared with that for “single-pincer” conjugates. Dynamic modelling of miRNA cleavage illustrated how such design enabled “Crabs” to drive catalytic turnover through simultaneous attacks at different locations of the RNA-DNA heteroduplex, presumably by producing smaller cleavage products and by providing toeholds for competitive displacement by intact miRNA strands. miRNA cleavage at the 5’-site, spreading further into double-stranded region, likely provided a synergy for RNase H1 through demolition of its loading region, thus facilitating enzyme turnover. Such synergy was critical for sustaining persistent disposal of continually-emerging oncogenic miRNAs. A single exposure to the best structural variant (Crab-p-21) prior to transplantation into mice suppressed their malignant properties and reduced primary tumor volume (by 85%) in MCF-7 murine xenograft models.
Original languageEnglish
Article number122604
Number of pages26
JournalBiomaterials
Volume309
Early online date6 May 2024
DOIs
Publication statusPublished - 1 Sept 2024

Keywords

  • Artificial enzyme
  • Supramolecular dynamics
  • Catalytic turnover
  • Oncogenic miRNA
  • Antitumor therapy
  • RNase H

Fingerprint

Dive into the research topics of 'Engineering supramolecular dynamics of self-assembly and turnover of oncogenic microRNAs to drive their synergistic destruction in tumor models'. Together they form a unique fingerprint.

Cite this